TY - JOUR
T1 - Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects
AU - Sen, Souvik
AU - An, Hongyu
AU - Menezes, Prema
AU - Oakes, Jonathan
AU - Eron, Joseph
AU - Lin, Weili
AU - Robertson, Kevin
AU - Powers, William
N1 - Funding Information:
Funding for the study was provided by the National Institute of Neurological Disorders and Stroke R01NS062754 .
Publisher Copyright:
© 2016 National Stroke Association
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Background Human immunodeficiency virus (HIV)-infected individuals are at high risk for ischemic stroke. To investigate the physiological basis for this risk, we used magnetic resonance imaging (MRI) to measure oxygen extraction fraction (OEF) and cerebral blood flow (CBF) in treatment-naive asymptomatic HIV-infected subjects and controls. Methods In treatment-naive asymptomatic HIV-infected subjects and age-, gender-, and race-matched controls, OEF was measured by MRI asymmetric spin–echo echo-planar imaging sequences and CBF was measured by MRI pseudocontinuous arterial spin labeling. Results Twenty-six treatment-naive HIV-infected subjects and 27 age-, gender-, race-matched controls participated. Whole-brain, gray matter (GM), and white matter OEF were not different between the groups (all P > .70). Unexpectedly, HIV-infected subjects had significantly higher CBF in cortical GM (72.9 ± 16.2 mL/100 g/min versus 63.9 ± 9.9 mL/100 g/min; P = .01) but not in subcortical GM (P = .25). Conclusions The observed increase in cortical GM CBF in treatment-naive HIV-infected subjects is unexpected, contrary to CBF decreases reported in HIV-infected subjects on treatment, and may represent an initial increase in metabolic activity due to an HIV-mediated inflammation.
AB - Background Human immunodeficiency virus (HIV)-infected individuals are at high risk for ischemic stroke. To investigate the physiological basis for this risk, we used magnetic resonance imaging (MRI) to measure oxygen extraction fraction (OEF) and cerebral blood flow (CBF) in treatment-naive asymptomatic HIV-infected subjects and controls. Methods In treatment-naive asymptomatic HIV-infected subjects and age-, gender-, and race-matched controls, OEF was measured by MRI asymmetric spin–echo echo-planar imaging sequences and CBF was measured by MRI pseudocontinuous arterial spin labeling. Results Twenty-six treatment-naive HIV-infected subjects and 27 age-, gender-, race-matched controls participated. Whole-brain, gray matter (GM), and white matter OEF were not different between the groups (all P > .70). Unexpectedly, HIV-infected subjects had significantly higher CBF in cortical GM (72.9 ± 16.2 mL/100 g/min versus 63.9 ± 9.9 mL/100 g/min; P = .01) but not in subcortical GM (P = .25). Conclusions The observed increase in cortical GM CBF in treatment-naive HIV-infected subjects is unexpected, contrary to CBF decreases reported in HIV-infected subjects on treatment, and may represent an initial increase in metabolic activity due to an HIV-mediated inflammation.
KW - Cerebral blood flow measurement
KW - MRI
KW - cerebrovascular disease
KW - infectious disease
KW - inflammation
UR - http://www.scopus.com/inward/record.url?scp=84964963592&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2016.03.045
DO - 10.1016/j.jstrokecerebrovasdis.2016.03.045
M3 - Article
C2 - 27160382
AN - SCOPUS:84964963592
SN - 1052-3057
VL - 25
SP - 1891
EP - 1895
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 8
ER -